Literature DB >> 18206116

The performance of the HPV16 real-time PCR integration assay.

Merja P Ruutu1, Satu-Maria Kulmala, Panu Peitsaro, Stina M Syrjänen.   

Abstract

OBJECTIVES: Integration of high risk human papillomavirus (HPV) into the host genome leads to viral oncogene deregulation predisposing to neoplastic progression. Integration can be detected from pap smear or biopsy and use as marker of progressive disease. DESIGN AND METHODS: We have previously developed a highly sensitive real-time PCR method to determine HPV integration frequency and viral load of HPV16 in clinical samples. The test is accurate and sensitive detecting approx. 50 copies of integrated HPV in the sample.
RESULTS: We found that a tenfold excess of episomal form to integrated form interferes with the test, regardless the amount of viral DNA. The same was true with background DNA more than 1500 ng in reaction.
CONCLUSIONS: Overall, this method is reproducible and suitable for high-throughput screening of clinical samples, but excess episomal copies might mask the integrated form.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18206116     DOI: 10.1016/j.clinbiochem.2007.12.014

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities.

Authors:  J R Montealegre; E C Peckham-Gregory; D Marquez-Do; L Dillon; M Guillaud; K Adler-Storthz; M Follen; M E Scheurer
Journal:  Gynecol Oncol       Date:  2017-12-21       Impact factor: 5.482

2.  Increase in viral load, viral integration, and gain of telomerase genes during uterine cervical carcinogenesis can be simultaneously assessed by the HPV 16/18 MLPA-assay.

Authors:  Wendy Theelen; Ernst-Jan M Speel; Michael Herfs; Martin Reijans; Guus Simons; Els V Meulemans; Marcella M Baldewijns; Frans C S Ramaekers; Joan Somja; Philippe Delvenne; Anton H N Hopman
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

3.  Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women.

Authors:  Agnihotram V Ramanakumar; Otelinda Goncalves; Harriet Richardson; Pierre Tellier; Alex Ferenczy; François Coutlée; Eduardo L Franco
Journal:  BMC Infect Dis       Date:  2010-11-11       Impact factor: 3.090

4.  Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study.

Authors:  Donghong Zhang; Qingying Zhang; Li Zhou; Leijun Huo; Yi Zhang; Zhongying Shen; Yi Zhu
Journal:  BMC Cancer       Date:  2010-11-26       Impact factor: 4.430

5.  Effect of β-sitosterol on the expression of HPV E6 and p53 in cervical carcinoma cells.

Authors:  Dali Cheng; Zhiqiang Guo; Shulan Zhang
Journal:  Contemp Oncol (Pozn)       Date:  2015-03-26

6.  Viral load, integration and methylation of E2BS3 and 4 in human papilloma virus (HPV) 16-positive vaginal and vulvar carcinomas.

Authors:  Gabriella Lillsunde Larsson; Gisela Helenius; Bengt Sorbe; Mats G Karlsson
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

7.  Diagnosis of 25 genotypes of human papillomaviruses for their physical statuses in cervical precancerous/cancerous lesions: a comparison of E2/E6E7 ratio-based vs. multiple E1-L1/E6E7 ratio-based detection techniques.

Authors:  Rong Zhang; Yi-feng He; Mo Chen; Chun-mei Chen; Qiu-jing Zhu; Huan Lu; Zhen-hong Wei; Fang Li; Xiao-xin Zhang; Cong-jian Xu; Long Yu
Journal:  J Transl Med       Date:  2014-10-02       Impact factor: 5.531

8.  Correlation between ebv co-infection and HPV16 genome integrity in Tunisian cervical cancer patients.

Authors:  Saloua Kahla; Sarra Oueslati; Mongia Achour; Lotfi Kochbati; Mohamed Badis Chanoufi; Mongi Maalej; Ridha Oueslati
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.